Company profile KTTA
After 38 days of this quarter the interest is at 69.0. Based on that we can calculate that during remaining 53 days it will total up to 165.0. Pasithea Therapeutics expected interest is significantly higher compared to previous quarter (+302.4%) and same quarter last year (+266.7%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 43 inf% YoY inf% QoQ |
| 2021 | 21 inf% YoY -51.2% QoQ | 100 inf% YoY 376.2% QoQ | 147 inf% YoY 47.0% QoQ | 373 767.4% YoY 153.7% QoQ |
| 2022 | 208 890.5% YoY -44.2% QoQ | 100 0.0% YoY -51.9% QoQ | 246 67.3% YoY 146.0% QoQ | 160 -57.1% YoY -35.0% QoQ |
| 2023 | 45 -78.4% YoY -71.9% QoQ | 63 -37.0% YoY 40.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 41 -74.4% YoY inf% QoQ |
| 2024 | 69 53.3% YoY 68.3% QoQ | - | - | - |
The average 5 years interest of Pasithea Therapeutics was 6.22 per week. The last year interest of Pasithea Therapeutics compared to the last 5 years has changed by -37.78%. This is something to be checked. This didn't exist 5 years ago.
After 38 days of this quarter the interest is at 80.0. Based on that we can calculate that during remaining 53 days it will total up to 192.0. Pasithea Therapeutics Corp expected interest is significantly higher compared to previous quarter (+92.0%) and same quarter last year (+255.6%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 34 | 28 -17.6% QoQ | 48 71.4% QoQ | 170 254.2% QoQ |
| 2020 | 39 14.7% YoY -77.1% QoQ | 100 257.1% YoY 156.4% QoQ | 105 118.8% YoY 5.0% QoQ | 138 -18.8% YoY 31.4% QoQ |
| 2021 | 153 292.3% YoY 10.9% QoQ | 177 77.0% YoY 15.7% QoQ | 33 -68.6% YoY -81.4% QoQ | 55 -60.1% YoY 66.7% QoQ |
| 2022 | 159 3.9% YoY 189.1% QoQ | 127 -28.2% YoY -20.1% QoQ | 239 624.2% YoY 88.2% QoQ | 75 36.4% YoY -68.6% QoQ |
| 2023 | 54 -66.0% YoY -28.0% QoQ | 68 -46.5% YoY 25.9% QoQ | 24 -90.0% YoY -64.7% QoQ | 100 33.3% YoY 316.7% QoQ |
| 2024 | 80 48.1% YoY -20.0% QoQ | - | - | - |
The average 5 years interest of Pasithea Therapeutics Corp was 7.72 per week. The last year interest of Pasithea Therapeutics Corp compared to the last 5 years has changed by -23.58%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 2.25%.
After 38 days of this quarter the interest is at 61.0. Based on that we can calculate that during remaining 53 days it will total up to 146.0. Pasithea Therapeutics stock expected interest is significantly higher compared to same quarter last year (+87.2%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 163 | 102 -37.4% QoQ | 45 -55.9% QoQ | 24 -46.7% QoQ |
| 2020 | 52 -68.1% YoY 116.7% QoQ | 39 -61.8% YoY -25.0% QoQ | 53 17.8% YoY 35.9% QoQ | 101 320.8% YoY 90.6% QoQ |
| 2021 | 88 69.2% YoY -12.9% QoQ | 90 130.8% YoY 2.3% QoQ | 63 18.9% YoY -30.0% QoQ | 122 20.8% YoY 93.7% QoQ |
| 2022 | 37 -58.0% YoY -69.7% QoQ | 44 -51.1% YoY 18.9% QoQ | 0 -100.0% YoY -100.0% QoQ | 35 -71.3% YoY inf% QoQ |
| 2023 | 78 110.8% YoY 122.9% QoQ | 59 34.1% YoY -24.4% QoQ | 87 inf% YoY 47.5% QoQ | 162 362.9% YoY 86.2% QoQ |
| 2024 | 61 -21.8% YoY -62.3% QoQ | - | - | - |
The average 5 years interest of Pasithea Therapeutics stock was 5.79 per week. The last year interest of Pasithea Therapeutics stock compared to the last 5 years has changed by 41.45%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 20.26%.
There is not enough data for Pasithea Therapeutics treatment to provide analysis
There is not enough data for Pasithea Therapeutics treatment to provide correlation calculation
There is not enough data for Pasithea Therapeutics treatment to provide analysis
There is not enough data for Pasithea Therapeutics RASopathies to provide analysis
There is not enough data for Pasithea Therapeutics RASopathies to provide correlation calculation
There is not enough data for Pasithea Therapeutics RASopathies to provide analysis
There is not enough data for Pasithea Therapeutics CNS disorders to provide analysis
There is not enough data for Pasithea Therapeutics CNS disorders to provide correlation calculation
There is not enough data for Pasithea Therapeutics CNS disorders to provide analysis
There is not enough data for Pasithea Therapeutics biotechnology to provide analysis
There is not enough data for Pasithea Therapeutics biotechnology to provide correlation calculation
There is not enough data for Pasithea Therapeutics biotechnology to provide analysis
There is not enough data for Pasithea Therapeutics clinics to provide analysis
There is not enough data for Pasithea Therapeutics clinics to provide correlation calculation
There is not enough data for Pasithea Therapeutics clinics to provide analysis
There is not enough data for Pasithea Therapeutics PAS-004 to provide analysis
There is not enough data for Pasithea Therapeutics PAS-004 to provide correlation calculation
There is not enough data for Pasithea Therapeutics PAS-004 to provide analysis
There is not enough data for Pasithea Therapeutics amyotrophic lateral sclerosis to provide analysis
There is not enough data for Pasithea Therapeutics amyotrophic lateral sclerosis to provide correlation calculation
There is not enough data for Pasithea Therapeutics amyotrophic lateral sclerosis to provide analysis